# Impact of HPV Vaccine On The Prevalence Of HPV In Norway

> **NCT02934724** · — · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 315 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Cervical Cancer
- Oropharyngeal Cancer

## Interventions

- **PROCEDURE:** Self sample from vagina
- **PROCEDURE:** Self sample from the oral cavity
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT02934724
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2020-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934724, "Impact of HPV Vaccine On The Prevalence Of HPV In Norway". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02934724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*